Pharmaceutical manufacturing combines strong, non-cyclical demand with clear policy support, as countries across South Asia and Africa push to reduce dependence on imported medicines and build domestic production of active ingredients and formulations. For an entrepreneur with the technical grounding and access to compliant facilities, pharma offers durable demand and defensible margins — but it is also one of the most tightly regulated sectors, where getting the process and quality systems right is not optional.
These handbooks cover pharmaceutical technology, formulations and manufacturing processes, prepared by EIRI's consultants with more than 45 years of industrial project experience, so an entrepreneur can understand the science and the process before investing.
The category covers finished-dosage manufacturing in the complete manufacturing technology of tablets, capsules, injectables, dry syrups and oral formulations, and the upstream side in the complete technology handbook on active pharmaceutical ingredients and bulk drugs — a strategically important area, since domestic API capacity is a stated priority in many markets working to reduce import dependence.
For the natural-medicine side, which shares this category, see the handbook of ayurvedic and herbal medicines with formulations and the handbook of ayurvedic medicines with formulations.
Each handbook covers the formulations, the manufacturing process for each dosage form, the plant and machinery involved, quality and standardisation requirements, and the technical parameters that govern a compliant product. The API handbook covers bulk-drug synthesis, while the dosage-form handbook covers the full range from tablets and capsules to injectables and syrups.
Pharmaceutical manufacturing is heavily regulated. In India it requires a drug manufacturing licence from the state drug controller under CDSCO oversight, GMP-compliant facilities, and qualified technical staff; ayurvedic products require an AYUSH licence. Export adds the destination country's own approvals. Compliance is integral to the business, not a formality. Confirm the full regulatory pathway for your specific products and location before investing.
In India, a drug manufacturing licence from the state drug controller under CDSCO oversight is required, along with GMP-compliant facilities and qualified technical staff. Ayurvedic products require an AYUSH licence instead. Requirements differ by country, so confirm the current position with the relevant drug authority.
Active pharmaceutical ingredient production is strategically important because many countries are working to reduce dependence on imported bulk drugs, and it often attracts policy support. It is capital- and technology-intensive, so a thorough understanding of the process and compliance is essential, which the API handbook provides.
Yes. The category covers modern pharmaceutical dosage forms and APIs, and also includes ayurvedic and herbal medicine formulations, so it spans both regulatory and product routes.
It is possible but demanding, given the licensing, GMP facility and technical-staff requirements. Many entrants begin with a defined product range and compliant contract or own facilities. The handbooks help you understand what a compliant operation actually requires before you commit.
Yes. Alongside these handbooks, EIRI prepares customised Detailed Project Reports for pharmaceutical, API and ayurvedic manufacturing units, suitable for finance and scheme applications and matched to your capacity and location.
Browse the handbooks above to find the guide for your intended product. Each can be purchased and downloaded, or request a free sample to review the depth first. For bank-ready project reports or customised documentation, send us your requirement.
Speak with our experts and get personalized guidance for your manufacturing business idea, project planning, machinery selection, and investment strategy.
